CAS 3547-07-7: 4-(p-Chlorophenoxy)butyric Acid

4-(4-Chlorophenoxy)Butanoic Acid

4-(4-Chlorophenoxy)butyric acid (4CBA) is a nitrobenzodiazepine derivative. It has been shown to bind to the benzodiazepine receptor at the same site as benzodiazepines, but with a different conformation. This drug has been shown to be an effective treatment for anxiety, but not depression. In addition, 4CBA has been shown to interact with GABA receptors and modulate their activity. It also appears that this drug may be useful in the treatment of epilepsy and other neurological disorders because it can enhance GABAergic transmission. 4CBA binds to the carboxylate site on GABA A receptors and inhibits chloride ion influx, which leads to membrane hyperpolarization. This binding also causes conformational changes in the receptor protein that have an effect on the binding of other ligands at the same site. The molecular modelling techniques used for this research showed that 4CBA binds in a similar manner as benzod